Diffusion Pharmaceuticals Inc (DFFN)

[abc1938]

MOJO JOYO GOOD FOR YOU I JUST loaded my last money this mmorning
at .83 pre market.

this last addition may be fuel that makes this engine begin
to take speed.

From todays PR : This guy us ready to TSC into partnerships, collaborations, and to oversee the US trials coming and eventually after that EAU approval for use for Covid-19 and other hypoxia related conditions.

Chris Galloway appointed as Chief Medical Officer :

Among his duties at La Jolla, he chaired and oversaw the investigator-initiated and collaborative research programs, as well as supported the commercial and medical teams for the launch of GIAPREZA(TM) (angiotensin II). Prior to La Jolla, he was Medical Director for global clinical development at the immuno-oncology company, Rakuten Medical. At Rakuten , he was involved in clinical development, operations, and trial execution from Phase 1 through Phase 3 in multiple indications. Previously he has served as Medical Affairs Director within Merck's immunotherapy division, and also led the team at DaVita Clinical Research as Medical Director and Principal Investigator specializing in early phase studies.